Biggest News Aggregation in the World
📰 Robert Davis News

Page 46 - Robert Davis News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Robert Davis. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Merck seeks GLP-1 drugs with benefits beyond weight loss

Newer diabetes and weight-loss drugs of the GLP-1 class like Novo Nordisk's Wegovy and Ozempic and Eli Lilly's Mounjaro and Zepbound are expected to together generate annual sales of over $100 billion by the end of the decade. Merck's experimental drug efinopegdutide, which belongs to the GLP-1 class and is being developed as a treatment for non-alcoholic steatohepatitis (NASH), also showed a "compelling" weight-loss benefit.
Pratik Jain Sriparna Roy Pooja Desai Robert Davis Merck Co Chief Executive Officer Robert Davis
Source: yahoo.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science